Filing Flows › IGC Pharma (IGC) › Recalls, complaints & regulation
IGC Pharma (IGC): clinical trials
IGC Pharma (IGC) beyond its filings: 1 active clinical trial.
IGC Pharma's latest quarter
IGC Pharma, Q3 2026: revenue $328K (+72% year over year), operating margin -588.7%, net loss $2.0M, operating cash flow −$1.4M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does IGC Pharma have?
1 active study on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.